Literature DB >> 15551010

[Quality of life after subtotal resection and gastrectomy for gastric cancer].

I Gockel1, S Pietzka, Th Junginger.   

Abstract

Recently, quality of life has become a main objective in surgical therapy. Apart from the oncological consequences, the quality of results after gastric carcinoma resection are mainly determined by social and psychological aspects of life, early postoperative complications, and long-term nutritive/functional parameters. Of 338 patients who underwent gastric resection for adenocarcinoma of the stomach, quality of life was assessed in 73 recurrence-free patients by means of the Gastrointestinal Life Quality Index (GLQI). The median age was 71.9 years, and surgery had been carried out at least 1 year prior to the investigation (median follow-up 4.5 years). Patients with subtotal gastric resection displayed significantly higher GLQI scores (120 [97-138] points) than patients with gastrectomy (116 [70-139] points;p=0.047). Among partial parameters of the life quality index, physical functions were significantly better after subtotal resection (p=0.040), while the emotional status (p=0.147) and social activities (p=0.337) did not differ between the two groups. Abdominal symptoms (p=0.081) and the nutritional function (p=0.228) were insignificantly different. The number of meals (4 vs. 5 meals per day) and the loss of weight since surgery (5 vs. 10 kg) were less after subtotal resection than after gastrectomy. However, the latter parameter did not reach statistical significance.

Entities:  

Mesh:

Year:  2005        PMID: 15551010     DOI: 10.1007/s00104-004-0950-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  22 in total

1.  [Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma].

Authors:  J D Roder; H J Stein; F Eckel; P Herschbach; G Henrich; K Böttcher; R Busch; J R Siewert
Journal:  Dtsch Med Wochenschr       Date:  1996-04-26       Impact factor: 0.628

2.  Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction.

Authors:  U Armbrecht; L Lundell; G Lindstedt; R W Stockbruegger
Journal:  Acta Chir Scand       Date:  1988-01

3.  Quality of life after gastrectomy in patients with carcinoma of the stomach.

Authors:  D Korenaga; H Orita; T Okuyama; S Moriguchi; Y Maehara; K Sugimachi
Journal:  Br J Surg       Date:  1992-03       Impact factor: 6.939

Review 4.  Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other.

Authors:  S Folkman; S Greer
Journal:  Psychooncology       Date:  2000 Jan-Feb       Impact factor: 3.894

5.  Food intake after gastrectomy for gastric carcinoma: the role of a gastric reservoir.

Authors:  B Liedman; H Andersson; B Berglund; I Bosaeus; I Hugosson; L Olbe; L Lundell
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

Review 6.  Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients--is reconstruction with a reservoir worthwhile?

Authors:  B Liedman
Journal:  Nutrition       Date:  1999-09       Impact factor: 4.008

7.  Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection.

Authors:  D Jentschura; M Winkler; N Strohmeier; B Rumstadt; E Hagmüller
Journal:  Hepatogastroenterology       Date:  1997 Jul-Aug

8.  [The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery].

Authors:  E Eypasch; S Wood-Dauphinée; J I Williams; B Ure; E Neugebauer; H Troidl
Journal:  Chirurg       Date:  1993-04       Impact factor: 0.955

9.  Choice of operative procedure for adenocarcinoma of the gastric antrum: a study based on TNM classification.

Authors:  D N Papachristou; J G Fortner
Journal:  J Surg Oncol       Date:  1982-12       Impact factor: 3.454

10.  Surgical treatment of gastric adenocarcinoma: impact on survival and quality of life. A prospective ten year study.

Authors:  M Braga; M Molinari; W Zuliani; L Foppa; L Gianotti; G Radaelli; M Cristallo; V Di Carlo
Journal:  Hepatogastroenterology       Date:  1996 Jan-Feb
View more
  7 in total

1.  A cost-effectiveness analysis of adjuvant chemoradiotherapy for resected gastric cancer.

Authors:  Samuel J Wang; Clifton D Fuller; Mehee Choi; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2008-03

2.  Efficacy and safety of XELOX and FOLFOX6 adjuvant chemotherapy following radical total gastrectomy.

Authors:  Shi Chen; Xingyu Feng; Yuanfang Li; Xiuhong Yuan; Zhiwei Zhou; Yingbo Chen
Journal:  Oncol Lett       Date:  2012-01-19       Impact factor: 2.967

3.  [Psychiatric comorbidities in visceral surgery patients with cancer].

Authors:  O Krauss; J Hauss; S Jonas; S Leinung; U Halm; C Albani; S Singer
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

4.  [Surgical management for early stage gastric cancer].

Authors:  K Ludwig; D Möller; J Bernhardt
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

5.  Influencing Factors and Effects of Treatment on Quality of Life in Patients With Gastric Cancer-A Systematic Review.

Authors:  Sophia Kristina Rupp; Andreas Stengel
Journal:  Front Psychiatry       Date:  2021-07-01       Impact factor: 4.157

6.  The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction.

Authors:  Wilko I Staiger; Ulrich Ronellenfitsch; Georg Kaehler; Hans Ulrich Schildhaus; Antonia Dimitrakopoulou-Strauss; Matthias Hm Schwarzbach; Peter Hohenberger
Journal:  World J Surg Oncol       Date:  2008-04-04       Impact factor: 2.754

7.  Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.

Authors:  Chongqing Tan; Liubao Peng; Xiaohui Zeng; Jianhe Li; Xiaomin Wan; Gannong Chen; Lidan Yi; Xia Luo; Ziying Zhao
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.